Browsing by Yonsei Author : Shin, Sang Joon

eperson profile image
Name:
Shin, Sang Joon [신상준]
orcid http://orcid.org/0000-0001-5350-7241
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7403647334)

Keyword Cloud

Researcher Network

Showing results 101 to 148 of 148

This table browses all dspace content
Issue DateTitleJournal Title
2012A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy.INVESTIGATIONAL NEW DRUGS
2012A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy.INVESTIGATIONAL NEW DRUGS
2012VIPoma that arose from the rectum in a 65-year-old male patient.INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
2012Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.EUROPEAN RADIOLOGY
2012Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea.CLINICAL THERAPEUTICS
2012Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis. CANCER RESEARCH AND TREATMENT
2012Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis. BRITISH JOURNAL OF CANCER
2012Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience. BMC CANCER
2012Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometryANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
2012Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteriaAMERICAN JOURNAL OF ROENTGENOLOGY
2011DNA methylation predicts recurrence from resected stage III proximal colon cancer CANCER
2011Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasisONCOLOGY
2011Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2011Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremityONCOLOGY
2011Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer CANCER CHEMOTHERAPY AND PHARMACOLOGY
2011Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancerJOURNAL OF MAGNETIC RESONANCE IMAGING
2011Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. RADIATION ONCOLOGY
2011Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancerINVESTIGATIONAL NEW DRUGS
2011Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.ONCOLOGY
2011Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancerANTI-CANCER DRUGS
2011A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy CANCER
2011Brain metastases from colorectal carcinoma: prognostic factors and outcomeJOURNAL OF NEURO-ONCOLOGY
2010A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy CANCER RESEARCH AND TREATMENT
2010The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study RADIATION ONCOLOGY
2010Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trialLUNG CANCER
2010A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancerINVESTIGATIONAL NEW DRUGS
2010Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticatorsJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2010Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerRADIOTHERAPY AND ONCOLOGY
2010A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2010Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2010Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patientsCANCER LETTERS
2009Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction YONSEI MEDICAL JOURNAL
2009Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCCJOURNAL OF NEURO-ONCOLOGY
2009Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea CANCER RESEARCH AND TREATMENT
2009Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neckCANCER CHEMOTHERAPY AND PHARMACOLOGY
2009Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancerINTERNATIONAL JOURNAL OF ONCOLOGY
2009Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trialsCANCER CHEMOTHERAPY AND PHARMACOLOGY
2008Mobilized CD34+ cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancerCANCER LETTERS
2008The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC.LUNG CANCER
2008Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer ANNALS OF ONCOLOGY
2008Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2008The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancerCANCER CHEMOTHERAPY AND PHARMACOLOGY
2008Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer.CANCER CHEMOTHERAPY AND PHARMACOLOGY
2008Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancerRADIOTHERAPY AND ONCOLOGY
2007Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinibJOURNAL OF CLINICAL ONCOLOGY
2007A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status BRITISH JOURNAL OF CANCER
2007Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapyACTA ONCOLOGICA

Browse

Links